跳至主要内容
临床试验/NCT06284291
NCT06284291Unknown不适用

Use of Transcranial Magnetic Stimulation (TMS) as a Surrogate of Pathophysiology in Genetic Epilepsies

Meyer Children's Hospital IRCCS2 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年11月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
150
试验地点
2
主要终点
TEP amplitude

研究概览

简要总结

Transcranial magnetic stimulation (TMS) uses electromagnetic induction as an efficient, painless, non-invasive method to generate a suprathreshold current at the level of the encephalon, and provide in vivo measurements of cortical excitability and reactivity at the level of the motor cortex (TMS-EMG) or the entire cortical mantle (TMS-EEG). This study proposes TMS measurements as a diagnostic tool in patients to understand mechanisms of epileptogenesis related to genetic mutations, and prognostic to guide and monitor precision treatments.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
3 Years 至 70 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Children aged >3 years and adults
  • Diagnosis of epilepsy with presumed or confirmed genetic etiology. Diagnosis of genetic epilepsy is made by next-generation sequencing (NGS) analysis
  • or Diagnosis of primary (non-hemicranial) headache, in the absence of alterations on neuroimaging, and no known genetic condition
  • Obtaining informed consent

排除标准

  • Age <3 years
  • Presence of contraindications to TMS: history of head or eye trauma with inclusion of metal fragments, cardiac pacemaker, arrhythmic heart disease, hearing implants, implantation of drug delivery devices, piercings or tattoos with metallic ink.
  • Pregnancy status

研究组 & 干预措施

Genetic epilepsy

Experimental

Patients with epilepsies of genetic etiology

干预措施: transcranial magnetic stimulation (TMS) (Diagnostic Test)

Patients with primary headache

Experimental

Patients with primary headache with non-migraine features

干预措施: transcranial magnetic stimulation (TMS) (Diagnostic Test)

结局指标

主要结局

TEP amplitude

时间窗: 24 months

Amplitude of each component of the TMS-evoked potential (mV)

ICF

时间窗: 24 months

Intracortical facilitation (ratio)

TEP latency

时间窗: 24 months

Latency of each component of the TMS-evoked potential (msec)

Resting motor threshold

时间窗: 24 months

Resting motor threshold (%MSO)

SICI

时间窗: 24 months

Short Interval intracortical inhibition (ratio)

LICI

时间窗: 24 months

Long Interval Intracortical inhibition (ratio)

次要结局

未报告次要终点

研究者

发起方
Meyer Children's Hospital IRCCS
申办方类型
Other
责任方
Principal Investigator
主要研究者

Simona Balestrini

Principal Investigator

Meyer Children's Hospital IRCCS

研究点 (2)

Loading locations...

相似试验